1. Home
  2. MRVI vs HIO Comparison

MRVI vs HIO Comparison

Compare MRVI & HIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MRVI
  • HIO
  • Stock Information
  • Founded
  • MRVI 2014
  • HIO 1993
  • Country
  • MRVI United States
  • HIO United States
  • Employees
  • MRVI N/A
  • HIO N/A
  • Industry
  • MRVI Biotechnology: Pharmaceutical Preparations
  • HIO Finance/Investors Services
  • Sector
  • MRVI Health Care
  • HIO Finance
  • Exchange
  • MRVI Nasdaq
  • HIO Nasdaq
  • Market Cap
  • MRVI 376.2M
  • HIO 368.0M
  • IPO Year
  • MRVI 2020
  • HIO N/A
  • Fundamental
  • Price
  • MRVI $3.24
  • HIO $3.87
  • Analyst Decision
  • MRVI Hold
  • HIO
  • Analyst Count
  • MRVI 9
  • HIO 0
  • Target Price
  • MRVI $4.54
  • HIO N/A
  • AVG Volume (30 Days)
  • MRVI 1.7M
  • HIO 305.3K
  • Earning Date
  • MRVI 11-06-2025
  • HIO 01-01-0001
  • Dividend Yield
  • MRVI N/A
  • HIO 10.33%
  • EPS Growth
  • MRVI N/A
  • HIO N/A
  • EPS
  • MRVI N/A
  • HIO N/A
  • Revenue
  • MRVI $219,830,000.00
  • HIO N/A
  • Revenue This Year
  • MRVI N/A
  • HIO N/A
  • Revenue Next Year
  • MRVI $7.27
  • HIO N/A
  • P/E Ratio
  • MRVI N/A
  • HIO N/A
  • Revenue Growth
  • MRVI N/A
  • HIO N/A
  • 52 Week Low
  • MRVI $1.67
  • HIO $3.52
  • 52 Week High
  • MRVI $8.29
  • HIO $4.03
  • Technical
  • Relative Strength Index (RSI)
  • MRVI 50.18
  • HIO 51.82
  • Support Level
  • MRVI $3.32
  • HIO $3.84
  • Resistance Level
  • MRVI $3.55
  • HIO $3.89
  • Average True Range (ATR)
  • MRVI 0.19
  • HIO 0.04
  • MACD
  • MRVI -0.04
  • HIO 0.01
  • Stochastic Oscillator
  • MRVI 8.82
  • HIO 84.62

About MRVI Maravai LifeSciences Holdings Inc.

Maravai LifeSciences Holdings Inc is a life sciences company that provides critical products that drive the development of groundbreaking vaccines, drug therapies, cell and gene therapies, and diagnostics. The group's solutions empower research into human diseases and support the entire biopharmaceutical development process from early discovery to commercialization. Its reportable segments are Nucleic acid production and biologics safety testing. It generates a majority of its revenue from Nucleic Acid Production and focuses on the manufacturing and sale of nucleic acid products to support the needs of customers' research, and therapeutic and vaccine programs. In addition, the segment also provides research products for labeling and detecting proteins in cells and tissue samples.

About HIO Western Asset High Income Opportunity Fund Inc.

Western Asset High Income Oppor Fd Inc is a diversified closed-end management investment company. The company's primary objective is to seek high current income and the secondary objective is capital appreciation. It invests a majority of its net assets in high-yield corporate debt securities and the rest in common stock equivalents, including options, warrants, and rights. The company invests in securities of companies from various sectors such as energy, technology, utilities, industrials, communications, finance, and capital goods among others.

Share on Social Networks: